Comparison of Generic Dasatinib Versus Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia with Reference to Early Molecular Response: Results from a Single-Center, Randomized Controlled Study from India
In: Blood, Jg. 140 (2022-11-15), Heft Supplement 1, S. 9640-9642
Online
serialPeriodical
Zugriff:
Titel: |
Comparison of Generic Dasatinib Versus Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia with Reference to Early Molecular Response: Results from a Single-Center, Randomized Controlled Study from India
|
---|---|
Autor/in / Beteiligte Person: | Singh, Sashi Kant ; Kumar, Karthik ; Nayak, Jhasaketan ; Porwal, Jasmine ; Morang, Sikha ; Dhingra, Gaurav ; Nath, Uttam Kumar |
Link: | |
Zeitschrift: | Blood, Jg. 140 (2022-11-15), Heft Supplement 1, S. 9640-9642 |
Veröffentlichung: | 2022 |
Medientyp: | serialPeriodical |
ISSN: | 0006-4971 (print) ; 1528-0020 (print) |
DOI: | 10.1182/blood-2022-158786 |
Sonstiges: |
|